Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Advanced Practice Nurse
The University of Texas MD Anderson Cancer Center
Outpatient Leukemia Nurse Practitioner
Division of Hematology/Oncology
Weill Cornell Medicine
New York, New York
Senior Clinical Editor
Associate Director, Scientific Services
Senior Director, Educational Strategy
Associate Scientific Director
Ashley Marostica, RN, MSN Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
The proposed learning activities are intended for oncology nurses, nurse practitioners, and other healthcare providers who manage and care for patients with AML, including nursing professionals affiliated with community and academic hospitals, oncology practices, or healthcare systems.
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 15, 2020, through May 14, 2021:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Living slideset on optimal management of CLL during the COVID-19 pandemic will be continually up-to-date as the situation evolves and new data emerge
Gain key clinical insights quickly with this short slideset from CCO on CAR T-cell therapy for hematologic malignancies.
Mary Jo Fidler, MD discusses key data in lung malignancies from ASCO 2020 and optimization of therapeutic benefit through management of cancer cachexia syndrome
John L. Marshall, MD discusses key data in GI malignancies from ASCO 2020 and optimizing therapeutic benefit through management of cancer cachexia
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.